PROCESSA PHARMACEUTICALS INC (PCSA) Stock Cash Flow
NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.53M | -11.12M | -27.42M | -11.43M | -14.41M | |||
| Depreciation Amortization | 580.00 | 200.00 | 788.50K | 791.00K | 803.70K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | -530.60K | -1.00M | |||
| Change In Working Capital | -412.46K | 605.20K | 543.60K | -1.18M | -140.40K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 816.97K | 2.45M | 16.49M | 3.63M | 11.61M | |||
| OPERATING CASH FLOW | -11.12M | -8.06M | -9.61M | -8.72M | -3.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -2.80K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -2.80K | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 862.50K | |||
| Stock Issued/Repurchased | 7.18M | 6.32M | -300.00K | 10.05M | 17.10M | |||
| Other Financing Activity | -24.15K | -52.70K | -88.80K | -250.90K | -95.20K | |||
| FINANCING CASH FLOW | 7.16M | 6.27M | -388.80K | 9.80M | 17.87M | |||
| CHANGE IN CASH | -3.97M | -1.80M | -9.99M | 1.08M | 14.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.12M | -8.06M | -9.61M | -8.72M | -3.14M | |||
| Capital Expenditure | N/A | -2.80K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -11.12M | -8.07M | -9.61M | -8.72M | -3.14M | |||
All data in USD